Provided is a novel Lactobacillus fermentum strain (Accession No. KCTC 14106BP) and a composition for preventing or treating a metabolic disease including the same. A Lactobacillus fermentum according to the present invention may inhibit fat accumulation and increase anti-inflammatory cells in white adipose tissue. In addition, the Lactobacillus fermentum may effectively inhibit fat accumulation in brown adipose tissue and in liver tissue. The Lactobacillus fermentum strain may exhibit excellent blood glucose improvement effect, and in particular, may reduce a fasting blood glucose level. The Lactobacillus fermentum strain may effectively ameliorate insulin resistance by improving glucose tolerance and increasing insulin sensitivity. Therefore, the Lactobacillus fermentum strain may be usefully used to prevent or treat a metabolic disease such as obesity.

The present invention provides a microbial consortium comprising two or more microorganisms, compositions and kits comprising the same and uses thereof in methods of treating immune-related conditions.

Provided are a bacterium for degrading sludge having a 16S rRNA gene comprising a nucleotide sequence having 97% or more identity to the nucleotide sequence represented by SEQ ID NO: 1, a bacterium having a 16S rRNA gene comprising the nucleotide sequence represented by SEQ ID NO: 1 with mutations of two bases or less, and having an ability to degrade a target microorganism, and a microbial preparation for degrading a target microorganism comprising a bacterium (a1) below. Bacterium (a1) is a bacterium having a 16S rRNA gene comprising a nucleotide sequence having 90% or more identity to the nucleotide sequence represented by SEQ ID NO: 1.

The present disclosure discloses a method for removing TBBPA in water, a microbial strain and a microbial agent, wherein the microbial strain is a domesticated Burkholderia cepacia strain, which is named Y17 with a conservation number GDMCC No. 62153. The microbial agent and the method for removing TBBPA in water with the microbial agent are that Y17 strains are colonized on the surface and pore channels of biochar, TBBPA in water is used as a carbon source, air and dissolved oxygen are used as oxygen sources, biochar provides the strains a growth microenvironment for degrading TBBPA in water, the strains are subjected to aerobic growth in water, and bio-enhanced degradation of TBBPA in water is performed by continuously degradation reaction. The removal method and the microbial strain as well as the microbial agent are high in degradation efficiency, environmental-friendly and low in cost, and can meet requirements on large-range promotion and application.

The present invention relates to Lactobacillus plantarum NK3 and Bifidobacterium longum NK49, which are novel lactic acid bacteria and, more particularly, to a composition comprising novel lactic acid bacteria useful for prevention and treatment of inflammatory diseases.

The present invention refers to exopolysaccharide molecules, conditioned media or compositions comprising said molecules or media. Moreover, the present invention refers to use of said exopolysaccharide molecules, conditioned media or compositions as prebiotic, preferably to boost immune system.

Bifidobacterium longum strains and cell wall fractions isolated from Bifidobacterium longum strains are useful in the prophylaxis or treatment of a respiratory viral infection in a subject. They are also useful in the prophylaxis of a secondary bacterial infection associated with a respiratory viral infection in a subject, especially a subject who is susceptible to respiratory infections.

Provided are a lysine decarboxylase immobilized cell and preparation method thereof.

The invention provides a bacterial composition which comprises from 10.sup.4 to 10.sup.12 cfu/g of Pediococcus pentosaceus cells which have the ability to induce the production of interleukin-10 to reduce inflammation in the intestinal tract among other features. Thus, the bacterial composition is useful in the amelioration of excessive crying in infants. Particularly, Pediococcus pentosaceus cells are from the strain deposited as CECT 8330. The bacterial composition can be in the form of a food supplement, a medicament, an infant formula, an edible product and a food product. Particularly, the composition is in the form of an infant food supplement in the form of oily suspension.

There is provided an isolated E. coli strain deposited at the International Depositary Authority of Canada (IDAC) on Jun. 20, 2013 and attributed accession number 200613-01. There is also provided methods of using this strain for preventing edema disease or diarrhea caused by an F18 pathogenic E. coli infection in an animal.